Bellbrook Names Cambio UK Distributor for Transcreener Products | GenomeWeb

NEW YORK (GenomeWeb News) – BellBrook Labs today announced a revised distribution agreement with Cambio to include BellBrook's full Transcreener product line of HTS assays.

Under the terms of the revised deal, Cambio becomes the exclusive distributor of BellBrook's Transcreener HTS assays in the UK. Cambio will also distribute BellBrook's new Transzyme product line of turnkey methyltransferase assay kits combining precalibrated purified methytransferase enzymes and substrates from Reaction Biology with BellBrook's Transcreener Epigen Methyltransferase detection reagents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.